Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|May 7, 1994
Ten year mortality in patients with suspected acute myocardial infarctionJ Launbjerg, P Fruergaard, J K Madsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Circadian variation in the pharmacokinetics of verapamilC M Jespersen, M Frederiksen, J F Hansen, et al.
Cardiology|January 1, 1994
Ten-year mortality of patients admitted to coronary care units with and without myocardial infarction. Risk factors from medical history and diagnosis at discharge. DAVIT-Study Group. Danish Verapamil Infarction TrialJ Launbjerg, P Fruergaard, J K Madsen, et al.
BMJ (Clinical Research Ed.)|January 21, 2000
Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic testsO W Nielsen, J F Hansen, J Hilden, et al.
Ugeskrift for Laeger|July 3, 1995
[10-year mortality of patients admitted to coronary units with or without confirmed diagnosis of myocardial infarction. A relation to anamnesis and diagnosis at discharge]J Launbjerg, P Fruergaard, J K Madsen, et al.
Journal of Internal Medicine|September 12, 2006
C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart diseaseA Sajadieh, O W Nielsen, V Rasmussen, et al.
Blood Pressure|June 16, 2000
Blood pressure level and relation to other cardiovascular risk factors in male hypertensive patients without clinical evidence of ischemic heart diseaseC T Larsen, C Sørum, J F Hansen, et al.
The Review of Scientific Instruments|February 6, 2008
Dynamic Hohlraums as x-ray sources in high-energy density scienceJ F Hansen, S G Glendinning, R F Heeter, et al.
The American Journal of Cardiology|June 20, 1996
Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fractionJ F Hansen, L Tingsted, V Rasmussen, et al.
American Heart Journal|August 1, 1997
Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction TrialJ F Hansen, L Hagerup, B Sigurd, et al.
Pageof 11